Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas.
Losa R, Fra J, López-Pousa A, Sierra M, Goitia A, Uña E, Nadal R, Del Muro JG, Gión M, Maurel J, Escudero P, Esteban E, Buesa JM.
Losa R, et al. Among authors: esteban e.
Cancer Chemother Pharmacol. 2007 Feb;59(2):251-9. doi: 10.1007/s00280-006-0263-0. Epub 2006 May 31.
Cancer Chemother Pharmacol. 2007.
PMID: 16736150
Clinical Trial.